Iterum Therapeutics PLC (ITRM)
| Market Cap | 46.30M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 3.86M |
| Shares Out | 183.35M |
| EPS (ttm) | 0.23 |
| PE Ratio | 1.10 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,962,281 |
| Open | 0.257 |
| Previous Close | 0.260 |
| Day's Range | 0.232 - 0.270 |
| 52-Week Range | 0.175 - 0.768 |
| Beta | 1.21 |
| Analysts | Sell |
| Price Target | 1.02 (+304.0%) |
| Earnings Date | Aug 12, 2022 |
About ITRM
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. The company was incorporated in 2015 and is headquartered in Dublin, Ireland. [Read more...]
Financial Performance
Financial StatementsAnalyst Forecast
According to 6 analysts, the average rating for ITRM stock is "Sell." The 12-month stock price forecast is 1.02, which is an increase of 303.96% from the latest price.
News
Iterum Therapeutics Shares Are Surging - Read Why
Iterum Therapeutics plc (NASDAQ: ITRM) has agreed with the FDA under the special protocol assessment (SPA) process on the design, endpoints, and statistical analysis of a Phase 3 trial for oral sulopene...
Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today?
Iterum Therapeutics (ITRM) stock is taking off on Monday as investors react to news of a clinical trial agreement with the FDA. The post Why Is Iterum Therapeutics (ITRM) Stock Up 73% Today?
Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch
More penny stocks to watch under $1 The post Penny Stocks To Buy Now? 7 Hot Stocks Under $1 To Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Iterum Therapeutics Announces Special Protocol Assessment (SPA) Agreement With the FDA
--SPA supports protocol for Phase 3 Clinical Trial of Oral Sulopenem for the treatment of Uncomplicated Urinary Tract Infections-- --Clinical Trial Expected to Begin Enrollment in Q4 2022--
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DUBLIN, Ireland and CHICAGO, July 06, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral ...
Iterum Therapeutics Reports First Quarter 2022 Financial Results
-General Alignment with FDA on Key Aspects of Design of Proposed Additional Clinical Trial- -Cash Runway into 2024-
Iterum Therapeutics Provides Regulatory Update
DUBLIN, Ireland and CHICAGO, May 11, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company”), a clinical-stage pharmaceutical company focused on developing next generation oral a...
Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
DUBLIN, Ireland and CHICAGO, April 25, 2022 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral a...
Iterum Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
- -Registration Trial for uUTI Planned in Second Half of 2022- - - -Cash Runway into 2024-- --Company to host conference call today at 8:30am ET--
Hot Penny Stocks to Watch in Early February 2022
Why investors are watching these penny stocks right now The post Hot Penny Stocks to Watch in Early February 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Iterum Therapeutics Appoints Sailaja Puttagunta, MD as Chief Medical Officer
DUBLIN, Ireland and CHICAGO, Dec. 13, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the “Company” or “Iterum”), a clinical-stage pharmaceutical company focused on developing next gene...
3 Reddit Penny Stocks to Watch in December 2021
Are these Reddit penny stocks on your watchlist right now? The post 3 Reddit Penny Stocks to Watch in December 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Iterum Therapeutics PLC (ITRM) Could Find Support Soon, Here's Why You Should Buy the Stock Now
Iterum Therapeutics PLC (ITRM) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreemen...
Iterum Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
- -Type B meeting with FDA requested to affirm design for additional Phase 3 trial needed for resubmission of NDA for Oral Sulopenem-- --Cash Runway into 2024-- --Iterum to host conference call today...
Top Penny Stocks For Your List Today? Check These 4 Out
Are these penny stocks on your watchlist right now? The post Top Penny Stocks For Your List Today?
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2021 Financial Results on November 12, 2021
DUBLIN, Ireland and CHICAGO, Nov. 05, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral an...
Hot Penny Stocks You Need to Know About Right Now
Looking for penny stocks to watch right now? Check these three out The post Hot Penny Stocks You Need to Know About Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt...
ITRM LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Iterum Therapeutic...
New York, New York--(Newsfile Corp. - October 4, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Iterum Therapeutic...
ITRM ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 4, 2021 in the Class Action Filed on Be...
New York, New York--(Newsfile Corp. - October 4, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Iterum Therapeutics Plc (NASDAQ: ITRM) all...
Last Few Hours for Investors to Actively Participate in Iterum Therapeutics plc (ITRM) Class Action - Bronstein, Gewi...
New York, New York--(Newsfile Corp. - October 4, 2021) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Iterum Therapeutics plc ("Iterum" or "th...
ITRM Final Deadline Today: Rosen, National Trial Lawyers, Encourages Iterum Therapeutics plc Investors with Losses to...
New York, New York--(Newsfile Corp. - October 4, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iterum Therapeutics plc (NASDAQ: ITRM) between No...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Iterum Therapeutics Plc of a Class Action Lawsuit a...
New York, New York--(Newsfile Corp. - October 4, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of It...
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ATVI, ITRM and KPLT
NEW YORK, NY / ACCESSWIRE / October 3, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to particip...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Iterum Therapeutics plc...
New York, New York--(Newsfile Corp. - October 1, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Iterum Therapeutics plc ("Iterum" or the "Company") (NASDAQ: ITRM) and...
CLASS ACTION UPDATE for ITRM, SLQT and SAM: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Sha...
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders...